Pharamceuticals

1 stories about Pharamceuticals
נאסדק

Ayala Pharmaceuticals Headed for Nasdaq IPO

07.01.20|Golan Hazani
The Israel-based cancer treatment developer wants to raise $100 million according to a $400 million company valuation